Takeda has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) to produce and sell Fruzaqla capsules 1mg/5mg (fruquintinib), an oral inhibitor of VEGFR-1, -2, and -3, for advanced or recurring colorectal cancer treatment...
AIIMS New Delhi and Intuitive, a global leader in minimally invasive technology and robotic-assisted surgery, signed an MoU to create a new training center for robotic-assisted surgery at AIIMS, New Delhi. The AIIMS da Vinci RAS training centre...
PCI Pharma Services, a top CDMO specializing in complex biopharma therapies, is dedicating over $365 million to enhance infrastructure for assembling and packaging drug-device combination products with advanced drug delivery systems, particularly...
Innate Pharma SA, a worldwide biotech firm in clinical stages advancing cancer immunotherapies, reported that the FDA has approved its IND application for a phase 1 clinical trial of IPH4502, a unique topoisomerase I inhibitor ADC targeting...
Antengene Corporation Limited, a top creative, internationally-operating biopharmaceutical company focused on finding, creating, and selling top-of-the-line medications for cancer, revealed that the Thailand Food and Drug Administration has given...
The government is considering overseeing the quality of imported medical devices through a risk-based method in which random samples will be selected for quality testing, with entire shipments of critical diagnostic kits being...
Suzhou-based CD Biopharma, a fast-growing biotech company in the clinical stage, has been approved by the FDA for its CD-001 Investigational New Drug (IND) application, marking the start of a phase I human trial...
AstraZeneca, a worldwide biopharmaceutical company focused on science, declared that FluMist is now the sole self-administered flu vaccine approved in the United States. FluMist, a nasal spray without needles, was authorized for...
Prime Minister Narendra Modi declared assistance of USD 7.5 million in sampling kits, detection kits, and vaccines for nations combatting cervical cancer. Addressing the Cancer Moonshot event in Delaware, Modi stressed India's dedication to...
InnoCare Pharma, a top biopharmaceutical company specializing in cancer and autoimmune disease treatments, declared the approval of the Investigational New Drug (IND) to carry out a clinical trial of ICP-248, a B-cell lymphoma-2 (BCL2) inhibitor...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")